These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6238821)

  • 1. Exogenous thymidine and reversal of the inhibitory effect of sulfamethoxazole-trimethoprim on streptococci.
    Coll PF; Ausina VR; Vernis JV; Mirelis BO; Prats GP
    Eur J Clin Microbiol; 1984 Oct; 3(5):424-6. PubMed ID: 6238821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of minimal amounts of thymidine on activity of trimethoprim-sulfamethoxazole against Staphylococcus epidermidis.
    Jones C; Stevens DL; Ojo O
    Antimicrob Agents Chemother; 1987 Feb; 31(2):144-7. PubMed ID: 3494425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of trimethoprim-sulfamethoxazole and incubation atmosphere on isolation of group A streptococci.
    Libertin CR; Wold AD; Washington JA
    J Clin Microbiol; 1983 Sep; 18(3):680-2. PubMed ID: 6415095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of L-streptococci in comparison with those of A-streptococci.
    Schaufuss P; Lämmler C; Niewerth B; Blobel H
    Med Microbiol Immunol; 1987; 176(3):169-73. PubMed ID: 3299018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
    Crider SR; Colby SD
    Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of activity of trimethoprim against gram-positive cocci by thymidine, thymine and 'folates'.
    Hamilton-Miller JM
    J Antimicrob Chemother; 1988 Jul; 22(1):35-9. PubMed ID: 3170389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility, growth kinetic and pathogenicity of thymidine-requiring Streptococcus species.
    Fu KP; Kimble EF; Coldreck RJ; Konopka EA
    Chemotherapy; 1984; 30(6):373-8. PubMed ID: 6335073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid.
    Zervos MJ; Schaberg DR
    Antimicrob Agents Chemother; 1985 Sep; 28(3):446-8. PubMed ID: 3935044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective and enhanced recovery of group A and B streptococci from throat cultures with sheep blood agar containing sulfamethoxazole and trimethoprim.
    Gunn BA; Ohashi DK; Gaydos CA; Holt ES
    J Clin Microbiol; 1977 Jun; 5(6):650-5. PubMed ID: 328529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole?
    Bowen AC; Lilliebridge RA; Tong SY; Baird RW; Ward P; McDonald MI; Currie BJ; Carapetis JR
    J Clin Microbiol; 2012 Dec; 50(12):4067-72. PubMed ID: 23052313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of thymidine on activity of trimethoprim and sulphamethoxazole.
    Stokes A; Lacey RW
    J Clin Pathol; 1978 Feb; 31(2):165-71. PubMed ID: 344347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of trimethoprim alone compared with trimethoprim-sulfamethoxazole and other antimicrobials against bacterial species associated with upper respiratory tract infections.
    Eliopoulos GM; Wennersten CB
    Diagn Microbiol Infect Dis; 1997 Sep; 29(1):33-8. PubMed ID: 9350413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of Streptococcus pyogenes to sulphamethoxazole, trimethoprim, and cotrimoxazole.
    Yourassowsky E; Vanderlinden MP; Schoutens E
    J Clin Pathol; 1974 Nov; 27(11):897-901. PubMed ID: 4613734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall.
    Goodhart GL
    JAMA; 1984 Nov; 252(19):2748-9. PubMed ID: 6333522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].
    Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D
    Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Susceptibility of Streptococcus pyogenes isolated from invasive infections to trimethoprim-sulfamethoxazole].
    Vigliarolo L; Gazzeli L; Bonofiglio L; Mollerach M; Lopardo H
    Medicina (B Aires); 2018; 78(5):311-314. PubMed ID: 30285923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a novel trimethoprim-sulfamethoxazole-containing medium (XT80) with kanamycin agar for isolation of antibiotic-resistant organisms from stool and rectal cultures of marrow transplant patients.
    Hamilton DJ; Ulness BK; Baugher LK; Counts GW
    J Clin Microbiol; 1987 Oct; 25(10):1886-90. PubMed ID: 3312287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening method for trimethoprim/sulfamethoxazole-resistant small colony variants of Staphylococcus aureus.
    Sato T; Kawamura M; Furukawa E; Fujimura S
    J Glob Antimicrob Resist; 2018 Dec; 15():1-5. PubMed ID: 29857058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection caused by thymidine-requiring, trimethoprim-resistant bacteria.
    King CH; Shlaes DM; Dul MJ
    J Clin Microbiol; 1983 Jul; 18(1):79-83. PubMed ID: 6604070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G; Wiedmer E
    Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.